Snowball logo
logo
CAPL

Caplin Point Laboratories Limited

1,856.70-45.10  (2.37%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently Asked Questions

What sector does Caplin Point Laboratories Limited (CAPLIPOINT) operate in?

Caplin Point Laboratories Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Caplin Point Laboratories Limited (CAPLIPOINT) current stock price?

As of the latest data, Caplin Point Laboratories Limited stock price is ₹1,856.70, with a previous close of ₹1,901.80. Caplin Point Laboratories Limited lost -₹45.10 in the last trading session, representing a -2.37% loss.

What is Caplin Point Laboratories Limited (CAPLIPOINT) current market capitalization?

Caplin Point Laboratories Limited market cap is approximately 141.13 billion.

What is Caplin Point Laboratories Limited (CAPLIPOINT) Earnings Per Share (EPS)?

The trailing EPS is ₹67.49, and the forward EPS is ₹79.70.

What is Caplin Point Laboratories Limited (CAPLIPOINT) Price-to-Earnings (P/E) ratio?

Caplin Point Laboratories Limited current P/E ratio is 27.51, with a forward P/E of 23.3.

What is Caplin Point Laboratories Limited (CAPLIPOINT) EBITDA?

Caplin Point Laboratories Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.94 billion.

Does Caplin Point Laboratories Limited (CAPLIPOINT) dividends?

Yes. Caplin Point Laboratories Limited pays semiannual dividends with a forward yield of 0.27% and a forward payout of ₹5.00 per share.

When is Caplin Point Laboratories Limited (CAPLIPOINT) next earnings report?

Caplin Point Laboratories Limited is expected to release its next earnings report on June 30, 2025.

What is Caplin Point Laboratories Limited (CAPLIPOINT) beta (volatility) score?

Caplin Point Laboratories Limited has a beta of 0.349, indicating lower volatility than the overall market.